Live attenuated intranasal influenza vaccine.

  title={Live attenuated intranasal influenza vaccine.},
  author={Susanna Esposito and Valentina Montinaro and Elena Groppali and Rossana Tenconi and Margherita Semino and Nicola Principi},
  journal={Human vaccines & immunotherapeutics},
  volume={8 1},
Annual vaccination is the most effective means of preventing and controlling influenza epidemics, and the traditional trivalent inactivated vaccine (TIV) is by far the most widely used. Unfortunately, it has a number of limitations, the most important of which is its poor immunogenicity in younger children and the elderly, the populations at greatest risk of severe influenza. Live attenuated influenza vaccine (LAIV) has characteristics that can overcome some of these limitations. It does not… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS

From This Paper

Topics from this paper.
9 Citations
0 References
Similar Papers


Publications citing this paper.
Showing 1-9 of 9 extracted citations

Similar Papers

Loading similar papers…